info iconCurrently, the share price for Clinitech Laboratory Ltd. is delayed.

close icon
Clinitech Laboratory Ltd. Logo

Clinitech Laboratory Ltd.

₹66.42
BSE
--   ( -- %) 1D



Income Statement

Also called a Profit & Loss statement, an Income Statement shows how a company has performed financially over a specific accounting period. It focuses on revenue, expenses, profits, and losses.
Created with Highcharts 7.2.2RevenueNet IncomeProfit Margin02.04.06.08.02.4%4.8%7.2%9.6%12%
Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Operating Revenue6.40+0.79%
Other Income0.04+100.00%
Total Income6.44+1.26%
Total Expenditure5.93+7.82%
EBIDT--
Depreciation0.44-2.22%
Interest0.07+16.67%
Tax0.13-48.00%
Net Profit0.37-39.34%

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Created with Highcharts 7.2.2Total AssetsTotal LiabilitiesTotal Debt to Equity02.04.06.08.00%16%32%48%64%
Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Total Current Assets2.71+38.27%
Total Non-Current Assets2.90-28.75%
Fixed assets2.66+40.74%
Total assets5.61-6.97%
Total Current Liabilities1.63-7.39%
Total Non-Current Liabilities0.43-77.37%
Total Capital Plus Liabilities5.61-6.97%
Total Shareholder Funds3.55+49.16%
Total Debt to Equity0.24-44.19%

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Created with Highcharts 7.2.2OperatingInvestingFinancing-4.8-3.2-1.601.6
Mar 2021Mar 2022Mar 2023Mar 2024
Particulars (In Cr)Mar 2024Y/Y Change
Cash from Operating Activity-1.40-212.00%
Cash from Financing Activities0.56+522.22%
Cash from Investing Activities0.75-215.38%
Net Cash Flow-0.08-111.76%
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer